{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0008-4510#drug","name":"Mylotarg","alternateName":"gemtuzumab ozogamicin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0008-4510"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761060"},{"@type":"PropertyValue","propertyID":"UNII","value":"8GZG754X6M"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"32fd2bb2-1cfa-4250-feb8-d7956c794e05"}],"activeIngredient":"GEMTUZUMAB OZOGAMICIN","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761060","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-4510"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T03:26:47.479Z"}}